Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
301
Stocks News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,831.50 | 53.60 | 0.61% |
CAC 40 | 7,878.46 | 111.75 | 1.44% |
DAX 40 | 24,549.56 | 342.65 | 1.42% |
Dow JONES (US) | 44,458.30 | 217.54 | 0.49% |
FTSE 100 | 8,867.02 | 12.84 | 0.15% |
HKSE | 23,914.79 | 22.47 | 0.09% |
NASDAQ | 20,611.34 | 192.87 | 0.94% |
Nikkei 225 | 39,616.80 | 204.48 | -0.51% |
NZX 50 Index | 12,736.69 | 31.92 | -0.25% |
S&P 500 | 6,263.26 | 37.74 | 0.61% |
S&P/ASX 200 | 8,593.70 | 55.10 | 0.65% |
SSE Composite Index | 3,505.58 | 12.53 | 0.36% |